Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.

Vanhoefer, U; Rougier, P; Wilke, H; Ducreux, M P; Lacave, A J; Van Cutsem, E; Planker, M; Santos, J G; Piedbois, P; Paillot, B; Bodenstein, H; Schmoll, H J; Bleiberg, H; Nordlinger, B; Couvreur, M L; Baron, B; Wils, J A.

J Clin Oncol ; 18(14): 2648-57, 2000 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-10894863

2.

Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.

Köhne, C-H; Wils, J; Lorenz, M; Schöffski, P; Voigtmann, R; Bokemeyer, C; Lutz, M; Kleeberg, C; Ridwelski, K; Souchon, R; El-Serafi, M; Weiss, U; Burkhard, O; Rückle, H; Lichnitser, M; Langenbuch, T; Scheithauer, W; Baron, B; Couvreur, M L; Schmoll, H J.

J Clin Oncol ; 21(20): 3721-8, 2003 Oct 15.

Artículo en Inglés | MEDLINE | ID: mdl-12963704

3.

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

Nitti, D; Wils, J; Sahmoud, T; Curran, D; Couvreur, M L; Lise, M; Rauschecker, H; dos Santos, J G; Stremmel, W; Roelofsen, F.

Eur J Cancer ; 33(8): 1209-15, 1997 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-9301444

4.

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group.

Wils, J; Blijham, G H; Wagener, Th; De Greve, J; Jansen, R L H; Kok, T C; Nortier, J W R; Bleiberg, H; Couvreur, M L; Genicot, B; Baron, B.

Eur J Cancer ; 39(3): 346-52, 2003 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-12565987

5.

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.

Nitti, D; Wils, J; Dos Santos, J Guimaraes; Fountzilas, G; Conte, P F; Sava, C; Tres, A; Coombes, R C; Crivellari, D; Marchet, A; Sanchez, E; Bliss, J M; Homewood, J; Couvreur, M L; Hall, E; Baron, B; Woods, E; Emson, M; Van Cutsem, E; Lise, M.

Ann Oncol ; 17(2): 262-9, 2006 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-16293676

6.

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research.

Rougier, P; Sahmoud, T; Nitti, D; Curran, D; Doci, R; De Waele, B; Nakajima, T; Rauschecker, H; Labianca, R; Pector, J C; Marsoni, S; Apolone, G; Lasser, P; Couvreur, M L; Wils, J.

Lancet ; 351(9117): 1677-81, 1998 Jun 06.

Artículo en Inglés | MEDLINE | ID: mdl-9734883

7.

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Klinkenbijl, J H; Jeekel, J; Sahmoud, T; van Pel, R; Couvreur, M L; Veenhof, C H; Arnaud, J P; Gonzalez, D G; de Wit, L T; Hennipman, A; Wils, J.

Ann Surg ; 230(6): 776-82; discussion 782-4, 1999 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-10615932

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group.

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.